Cargando...
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads worldwide and leads to an unprecedented medical burden and lives lost. Neutralizing antibodies provide efficient blockade for viral infection and are a promising category of biological therapies. Here, using SARS-CoV-2 spike recept...
Gardado en:
| Publicado en: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7483421/ https://ncbi.nlm.nih.gov/pubmed/32913273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-18387-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|